Todd Rumans, MD
Otolaryngology · Batesville, ARNPI 1124097209
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 45 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Organogenesis Inc. at 38.5% of the total.
Across 45 payments — averaging $21.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$374
- Stryker$134
- GSK$71
- KCI USA, Inc.$58
- Urogen Pharma, Inc.$46
- Inspire Medical Systems, Inc.$31
- plus $258 from 15 others
What the payments were for
- Food & beverage$972100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 15 | $374 |
| Stryker | 4 | $134 |
| GSK | 4 | $71 |
| KCI USA, Inc. | 4 | $58 |
| Urogen Pharma, Inc. | 2 | $46 |
| Inspire Medical Systems, Inc. | 1 | $31 |
| TELA Bio, Inc. | 1 | $31 |
| 180 Medical, Inc. | 1 | $27 |
| Olympus America Inc. | 1 | $20 |
| Philips North America LLC | 1 | $19 |
| Davol Inc. | 1 | $18 |
| Bayer | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Covidien LP | 1 | $17 |
| Teleflex LLC | 1 | $15 |
| Axonics, Inc. | 1 | $13 |
| Smith+Nephew | 1 | $13 |
| Innocoll Pharmaceuticals Limited | 1 | $12 |
| Intersect ENT, Inc. | 1 | $12 |
| Tetraphase Pharmaceuticals, Inc. | 1 | $12 |
| Amgen | 1 | $12 |
How this compares
$972 in reported general payments places this provider in the 55th percentile of 72 otolaryngology providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 47 | $5,417 |
| Fluticasone Propionate | 117 | $1,237 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 19 | $252 |
| Ipratropium Bromide | 11 | $246 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 15 | $203 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $107 |
| Cephalexin | 23 | $93 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Batesville
- Brian LawtonBatesville$85
- Patricia BellHarrison$82K
- Cory VaughnSpringdale$7K
- Jeffrey KirschConway$6K
- Patrick FraleyConway$5K
- Sharon TomaskiEl Dorado$5K
- Tyler BoneJonesboro$5K
- Rafael MarreroConway$4K
- Matthew BridgesRogers$4K
- Michael MarshFort Smith$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.